In a report published Wednesday, Jefferies analyst Raj Denhoy reiterated a Hold rating on Medtronic MDT, and raised the price target from $48.00 to $53.00.
In the report, Jefferies noted, “Medtronic put up a solid F4Q beat driven in part by growth in US ICDs and Spine of all places. Initial F14 guidance of +3-4% cc growth was in line and the outlook remains generally stable with some positive trends in key businesses. Although F4Q had more evidence of a turnaround, underlying markets remain weak, EU still uncertain, R&D returns more a F15 story, and valuation is full. Estimates and PT go higher but rating stays at Hold.”
Medtronic closed on Tuesday at $49.89.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.